V\u00e4it\u00f6kset tutkimuslaitos Minervasta<\/h1>\n<\/div><\/div><\/div><\/div><\/div>![](\"https:\/\/minervainstitute.fi\/wp-content\/uploads\/2024\/01\/vaitokset1.jpg\" "\\"vaitokset1\\"")
<\/span><\/div><\/div><\/div><\/div><\/div>2025<\/strong><\/p>\nHannes Frederik Bode: Epigenetics of environmental risk factors for breast cancer in cancer-discordant twin pairs. 1.10.2025.<\/p>\n
Abel Szkalisity: Computational techniques in lipid metabolic studies. 7.7.2025.<\/p>\n
David Micinski: The actin cytoskeleton and axon initial segment function. 21.10.2025.<\/p>\n<\/div><\/div><\/div>
<\/span><\/div><\/div><\/div><\/div><\/div>2024<\/strong><\/p>\nVignesh Srinivasan: Novel roles of the protein deubiquitinase USP14 in proteostasis regulation and cell stress responses. 11.10.2024.<\/p>\n
Juuso Taskinen: The role of endoplasmic reticulum membrane contact sites in human endothelial cells. 4.10.2024.<\/p>\n
Taru Knuutinen: The importance of calcium channels in thyroid cancer. 27.9.2024.<\/p>\n
Michelle Renlund-Vikstr\u00f6m: Cardiovascular health in preadolescent children following in-utero exposure to pre-eclampsia. 7.6.2024.<\/p>\n
Suneeta Narumanchi: Septin7b and let-7c modulate cardiac function and regeneration in zebrafish. 5.6.2024<\/p>\n
2023<\/strong><\/p>\nJuho Pirhonen: Mechanisms of lipid deposition: Application of novel omics techniques, tissue imaging methods, and their synergistic deployment in lipid research. 29.9.2023<\/p>\n
Puspa Khanal: Molecular regulation of the dendritic spine initiation. August 11, 2023.<\/p>\n
Selina M\u00e4kinen: Send in the signals: Studies on the mechanism of insulin resistance in human skeletal muscle. February 4, 2023.<\/p>\n
2022<\/strong><\/p>\nMari Lahelma: Lifestyle factors and lipid metabolism in non-alcoholic fatty liver disease, the metabolic syndrome, and atherosclerotic cardiovascular disease. December 16, 2022.<\/p>\n
Maria Ahonen Mehmeti: Mechanisms of adipocyte dysfunction in metabolic disease and cancer. December 9, 2022.<\/p>\n
2021<\/strong><\/p>\nKien Dang: Diagnostic and prognostic role of expressed KRAS and BRAF mutations in MAPK\/ERK-driven cancers. June 21, 2021.<\/p>\n
Annika Koponen: ORP2 – a lipid-binding protein controlling cellular cholesterol transport and signal transduction. April 1, 2021.<\/p>\n
Kecheng Zhou: Crosstalk between sphingolipid metabolism and nutrient signaling: Studies on LAPTM4B. March 4, 2021.<\/p>\n
2020<\/strong><\/p>\nHanna Ruhanen: Hepatic lipid metabolism in cardiometabolic diseases \u2013 protective and adverse effects of genetic variants. October 13, 2020.<\/p>\n
Dan Pham Duc: Novel roles of p75 neurotrophin receptor in Low-density lipoprotein receptor regulation and lipid signaling. June 4, 2020.<\/p>\n
Veijo Salo: Lipogenic subdomains of the ER: The role of seipin. April 17, 2020.<\/p>\n
Amr Abouelezz: The structure and dynamics of the actin cytoskeleton in the axon initial segment. February 28, 2020.<\/p>\n
2019<\/strong><\/p>\nIryna Hlushchenko: Actin regulation in dendritic spines: From synaptic plasticity to animal behavior and neurodevelopmental disorders. August 16, 2019.<\/p>\n
2018<\/strong><\/p>\nPanu Luukkonen: Heterogeneity of non-alcoholic fatty liver disease \u2013 Genetic and nutritional modulation of hepatic lipid metabolism. September 7, 2018.<\/p>\n
Henriikka Kentala: ORP2 \u2013 A sterol sensor controlling hepatocellular bioenergetics and actin cytoskeletal functions. August 18, 2018<\/p>\n
Raghavendra Mysore: Novel molecular regulators of adipose tissue metabolism. May 18, 2018.<\/p>\n
Anna Tikka: Characterization of ANGPTL3 deficiency and molecular mechanisms of ANGPTL3 deficiency-induced hypolipodemia. January 19, 2018.<\/p>\n
Susanna Lallukka: Non-alcoholic fatty liver disease: The role of insulin resistance, inflammation and the PNPLA3 I148M variant. January 13, 2018.<\/p>\n
2017<\/strong><\/p>\nJenni Hyysalo: Prevalence and Genetics of Non-Alcoholic Fatty Liver Disease. December 16, 2017.<\/p>\n
Elina Isokuortti: Non-alcoholic fatty liver disease \u2013 Studies on pathogenesis and diagnosis. October 28, 2017.<\/p>\n
Boris Vassilev: Studies on proteins influencing cancer progression and regulating endocytic lipid trafficking. April 28, 2017.<\/p>\n
2016<\/strong><\/p>\nJohanna M\u00e4kel\u00e4: Neuroprotective effects of PGC-1\u03b1 activators in dopaminergic neurons. May 20, 2016.<\/p>\n
2015<\/strong><\/p>\nVeronica Kalhori: Sphingosine-1-phosphate-evoked invasion of follicular thyroid cancer cells: Evidence for the involvement of HIF-1a, MMP2 and MMP9. September 11, 2015.<\/p>\n
Tho Huu Ho: Development of amplification-based technologies for enrichment of nucleic acids with difficult sequences or low-abundance point mutations. February 13, 2015.<\/p>\n
2014<\/strong><\/p>\nAlise Hyrskyluoto: Endoplasmic reticulum stress, regulation of autophagy and ubiquitin-proteosome system in cellular models of Huntington’s Disease. September 12, 2014.<\/p>\n
Leena Juurinen: Insulin therapy in type 2 diabetes – Initiation, impact on liver fat, role of combination therapy with glitazones or glinides. May 16, 2014.<\/p>\n
Jere Paavola: Aberrant intracellular calcium cycling in the heart – Mechanistic insights into catecholaminergic polymorphic ventricular tachycardia and heart failure. March 28, 2014.<\/p>\n
2013<\/strong><\/p>\nAnders Eriksson-Paloj\u00e4rvi: Neurohumoral responce and pathophysiologic changes during progresson of mitral reurgitation in the Cavalier King Charles spaniel. November 29, 2013.<\/p>\n
Wei Wang: Studies on the transcriptional and enzymatic control of steroid metabolism: Regulation by lysosomal acid lipase, 24-dehydrocholesterol reductace, and amyloid precursor protein. November 28, 2013.<\/p>\n
Raili Koivuniemi: Regulation of neural progenitor cell proliferation and fate by proteolytic pathways and inflammatory signals in the brain. September 6, 2013.<\/p>\n
You Zhou: Oxysterol binding protein homologues: Novel functions in intracellular transport and adipogenesis. January 25, 2013.<\/p>\n
2012<\/strong><\/p>\nNoora Putkonen: Organelle specific mechanism of neuronal cell death. October 26, 2012.<\/p>\n
Terhi Vihervaara: The role of oxysterol binding proteins in macrophages. October 5, 2012.<\/p>\n
Paulina Skrobuk: Glucose and lipid metabolism in human skeletal muscle. September 7, 2012.<\/p>\n
2011<\/strong><\/p>\nKsenia Sevastianova: Combination antiretroviral therapy-associated lipodystrophy: insights into pathogenesis and treatment. November 25, 2011.<\/p>\n
2010<\/strong><\/p>\nP\u00e4ivi Lakkisto: Heme oxygenase-1 in cardiovascular diseases. December 17, 2010.<\/p>\n
Minna Kairisalo: Oxidative stress and XIAP signalling in neuronal cells. October 15, 2010.<\/p>\n
Sami Reijonen: Endoplasmic reticulum stress and cell death mechanisms in the cell model of Huntington’s disease. October 8, 2010.<\/p>\n
Nina Bergelin: Interactions between sphingosine 1-phosphate and vascular endothelial growth factor signaling in thyroid carcinoma cells. September 17, 2010.<\/p>\n
Tero Viitanen: GABAa reseptor mediated signalling in the brain: inhibition, shunting and excitation. June 23, 2010.<\/p>\n
Janne Makkonen: Adipose tissue inflammation, liver fat and insulin resistance in humans. June 18, 2010.<\/p>\n
2008<\/strong><\/p>\nAnna Kotronen: Liver fat in the metabolic syndrome and type 2 diabetes.<\/p>\n
2007<\/strong><\/p>\nCia Ramstr\u00f6m: Ceramides and DAG as regulators of potassium channel function.<\/p>\n
2006<\/strong><\/p>\nTomas Blom: Sphingolipid-mediated regulation of cellular calcium signaling and survival.<\/p>\n
2005<\/strong><\/p>\nMirja Tiikkainen: Effects of weight loss, rosiglitazone and metformin on liver fat content, insulin resistance and gene expression in adipose tissue\u201d<\/p>\n
2004<\/strong><\/p>\nMarjo Tamminen: Vascular and Platelet Function in Insulin Resistance<\/p>\n
Esa Lepp\u00e4nen: Experimental basis for standardization of blood specimen collection. (started in Minerva but was completed in Jyv\u00e4skyl\u00e4)<\/p>\n
2003<\/strong><\/p>\nElena Korsheninnikova: Molecular mechanisms of insulin resistance in human skeletal muscle and lipodystrophic adipose tissue. July 4, 2003.<\/p>\n
Robert Bergholm: Effects of weight loss, physical training and anti-inflammatory therapy on endothelial function in vivo.<\/p>\n
Jussi Sutinen: Pathogenesis and treatment of lipodystrophy in HIV-infected patients receiving highly active antiretroviral therapy.<\/p>\n
2002<\/strong><\/p>\nNina Uhlenius: Angiotensin II and nitric oxide in chronic experimental nephritis.<\/p>\n
2001<\/strong><\/p>\nJukka Westerbacka: Insulin action on large artery stiffness in normal and insulin resistant subjects.<\/p>\n
Satu Vehkavaara: Identification and treatment of endothelial dysfunction and cardiovascular risk markers in disorders of glucose metabolism and in postmenopausal women.<\/p>\n
2000<\/strong><\/p>\nBeno\u00eet Dugu\u00e9: Variabilit\u00e9 Biologique. Influence des facteurs preanalytiques in vivo (stress physique, stress psychologique, chronobiologie) sur les r\u00e9sultants d\u2019analyses de marqueurs biologiques sanguins et cellulaires.<\/p>\n
1999<\/strong><\/p>\nMarkus Sundblom: Neuropeptide FF in human blood and cerebrospinal fluid.<\/p>\n
1998<\/strong><\/p>\nLeena Karhap\u00e4\u00e4: Effects of caffeine and thimerosal on the regulation of intracellular calsium concentration in GH4C1 rat pituitary cells.<\/p>\n
1997<\/strong><\/p>\nMarja-Leena Sirvi\u00f6: Endothelin-1; cardiopulmonal expression, metabolism and regulation of atrial natriuretic peptide release.<\/p>\n
1995<\/strong><\/p>\nAntti Virkam\u00e4ki: Mechanism and causes of abnormal carbohydrate metabolism during experimental and natural infections.<\/p>\n
1994<\/strong><\/p>\nOuti Saijonmaa: Endothelin-1: Plasma levels in cold pressor test and regulation in endothelial cells.<\/p>\n
Karri Helin: Neutral endopeptidase inhibition in experimental heart failure.<\/p>\n
1991<\/strong><\/p>\nSari Tikanoja: Free thyroid hormones in serum: performance of different assay methodologies in thyroid diseases and non-thyroidal illnesses.<\/p>\n
1989<\/strong><\/p>\nPer-Henrik Groop: The relationship between gastric inhibitory polypeptide (GIP) and beta-cell function in man.<\/p>\n
Tuula Tikkanen: Atrial natriuretic peptide in experimental heart failure.<\/p>\n
Kaj Mets\u00e4rinne: Renin substrate in human plasma and amniotic fluid.<\/p>\n
1987<\/strong><\/p>\nKid T\u00f6rnquist: 1,25-dihydroxyvitamin D3 and the secretion of thyrotropin and prolactin from the rat pituitary gland.<\/p>\n
Katarina Rosenl\u00f6f: Erythropoietin: receptor and comparison with renin substrate.<\/p>\n
1986<\/strong><\/p>\nVirpi Oksanen: Neurosarcoidosis: A clinical, laboratory and neuroradiological study.<\/p>\n
Jean-Louis Gu\u00e9ant:<\/p>\n
1984<\/strong><\/p>\nMarkku M. Nieminen: Renin-Aldosterone axis in man following ingestion of ethanol.<\/p>\n
Christel Lamberg-Allardt: Serum 25-hydroxy-vitamin D concentration and vitamin D intake.<\/p>\n
Terje Forslund: Induction of rat angiotensin converting enzyme by captopril and enalapril.<\/p>\n
1983<\/strong><\/p>\nIlkka Immonen: Factors affecting human plasma renin substrate concentration with emphasis on estrogens and pregnancy.<\/p>\n
1982<\/strong><\/p>\nJaakko Linkola: Strain differences in water and electrolyte metabolism between alcohol preferring (AA) and alcohol avoiding (ANA) rats.<\/p>\n
Tom Petterson: Pleural effusions in infectious, neoplastic and connective tissue diseases. A study of cellular and immunological reactions with emphasis on the role of T and B lymphoytes.<\/p>\n
1981<\/strong><\/p>\nIlkka Kouvonen: Structure of the porcine intestinal intrinsic factor (IF) receptor.<\/p>\n
Ilkka Tikkanen: Hypertensive effect of autoimmune nephritis in DOCA-NaCl-treated and in spontaneously hypertensive rats.<\/p>\n
Georg Borgstr\u00f6m: Clinical implications of chromosome aberrations in hematologic neoplasia.<\/p>\n
1980<\/strong><\/p>\nCarola Gr\u00f6nhagen-Riska: Angiotensin converting enzyme and sarcoidosis.<\/p>\n
Fredrika Pekonen: The interaction of thyrotropin with its receptors.<\/p>\n
1978<\/strong><\/p>\nThomas T\u00f6tterman: Thyroid-infiltrating immunocompetent cells in human autoimmune thyroid disease.<\/p>\n
George Marcoullis: Soluble and membrane-bound proteins involved in vitamin B12 transport.<\/p>\n
Pertti Soveri: Renin in human pregnancy and during oral contraception.<\/p>\n
1975<\/strong><\/p>\nGustav W\u00e4gar: Effect of TSH and cyclic adenosine 3\u00b4, 5\u00b4-monophosphate on thyroidal protein synthesis.<\/p>\n
Jim Schr\u00f6der: Passage of blood cells between foetus and mother.<\/p>\n
1974<\/strong><\/p>\nAriel Gordin: Thyrotrophin in human serum; A methodological and clinical study in diseases of the thyroid gland.<\/p>\n
Ulf-H\u00e5kan Stenman: Studies on cobalophilin. Vitamin B12-binding proteins of R-type.<\/p>\n
Ritva-Kajsa Selander: Kromosomala makromolekylers effekt p\u00e5 vissa akridinderivats absorption och fluorescens.<\/p>\n
1973<\/strong><\/p>\nAldur Eriksson: Human twinning in and around the \u00c5land Islands.<\/p>\n
1972<\/strong><\/p>\nJorma M\u00e4enp\u00e4\u00e4: Hypothyroidism and autoimmune thyroiditis in childhood.<\/p>\n
Risto Kala: Venous plasma angiotensin II in man. Diurnal variation and response to various postural stimuli and exercise.<\/p>\n
1971<\/strong><\/p>\nJohan Wennstr\u00f6m: Effect of ionizing radiation on the chromosomes in meiotic and mitotic cells.<\/p>\n
Frej Fyhrquist: Radioimmunoassay of plasma angiotensin II in patients with hypertension, in renal transplant recipients, and in anephric patients.<\/p>\n
1970<\/strong><\/p>\nJohan Edgren: Effect of cysteine on chromosome aberrations induced by radiation of human lymphocytes in vitro.<\/p>\n
1969<\/strong><\/p>\nTeddy Weber: Isolation and characterization of a lymphocyte-stimulating leucoagglutinin from red kidney beans. (Phaseolus vulgaris).<\/p>\n
1968<\/strong><\/p>\nRolf Nordman: Endemic goitre in Finland in the light of thyroids of newborn in 1962-1965.<\/p>\n
Kristian Liewendahl: Iodochloroxyquinoline and the thyroid gland. Metabolism of iodochloroxyquinoline iodine and its effect on the thyroid iodine metabolism in rats.<\/p>\n
1964<\/strong><\/p>\nKaj Simons: Vitamin B12 binders in human body fluids and blood cells.<\/p>\n
1962<\/strong><\/p>\nAlbert de la Chapelle: Cytogenetical and clinical observations in female gonadal dysgenesis.<\/p>\n<\/div><\/div><\/div><\/div><\/div><\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":0,"parent":758,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"100-width.php","meta":{"footnotes":""},"class_list":["post-773","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/minervainstitute.fi\/fi\/wp-json\/wp\/v2\/pages\/773","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/minervainstitute.fi\/fi\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/minervainstitute.fi\/fi\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/minervainstitute.fi\/fi\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/minervainstitute.fi\/fi\/wp-json\/wp\/v2\/comments?post=773"}],"version-history":[{"count":21,"href":"https:\/\/minervainstitute.fi\/fi\/wp-json\/wp\/v2\/pages\/773\/revisions"}],"predecessor-version":[{"id":2342,"href":"https:\/\/minervainstitute.fi\/fi\/wp-json\/wp\/v2\/pages\/773\/revisions\/2342"}],"up":[{"embeddable":true,"href":"https:\/\/minervainstitute.fi\/fi\/wp-json\/wp\/v2\/pages\/758"}],"wp:attachment":[{"href":"https:\/\/minervainstitute.fi\/fi\/wp-json\/wp\/v2\/media?parent=773"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
<\/span><\/div><\/div><\/div><\/div><\/div>2025<\/strong><\/p>\n Hannes Frederik Bode: Epigenetics of environmental risk factors for breast cancer in cancer-discordant twin pairs. 1.10.2025.<\/p>\n Abel Szkalisity: Computational techniques in lipid metabolic studies. 7.7.2025.<\/p>\n David Micinski: The actin cytoskeleton and axon initial segment function. 21.10.2025.<\/p>\n<\/div><\/div><\/div> 2024<\/strong><\/p>\n Vignesh Srinivasan: Novel roles of the protein deubiquitinase USP14 in proteostasis regulation and cell stress responses. 11.10.2024.<\/p>\n Juuso Taskinen: The role of endoplasmic reticulum membrane contact sites in human endothelial cells. 4.10.2024.<\/p>\n Taru Knuutinen: The importance of calcium channels in thyroid cancer. 27.9.2024.<\/p>\n Michelle Renlund-Vikstr\u00f6m: Cardiovascular health in preadolescent children following in-utero exposure to pre-eclampsia. 7.6.2024.<\/p>\n Suneeta Narumanchi: Septin7b and let-7c modulate cardiac function and regeneration in zebrafish. 5.6.2024<\/p>\n 2023<\/strong><\/p>\n Juho Pirhonen: Mechanisms of lipid deposition: Application of novel omics techniques, tissue imaging methods, and their synergistic deployment in lipid research. 29.9.2023<\/p>\n Puspa Khanal: Molecular regulation of the dendritic spine initiation. August 11, 2023.<\/p>\n Selina M\u00e4kinen: Send in the signals: Studies on the mechanism of insulin resistance in human skeletal muscle. February 4, 2023.<\/p>\n 2022<\/strong><\/p>\n Mari Lahelma: Lifestyle factors and lipid metabolism in non-alcoholic fatty liver disease, the metabolic syndrome, and atherosclerotic cardiovascular disease. December 16, 2022.<\/p>\n Maria Ahonen Mehmeti: Mechanisms of adipocyte dysfunction in metabolic disease and cancer. December 9, 2022.<\/p>\n 2021<\/strong><\/p>\n Kien Dang: Diagnostic and prognostic role of expressed KRAS and BRAF mutations in MAPK\/ERK-driven cancers. June 21, 2021.<\/p>\n Annika Koponen: ORP2 – a lipid-binding protein controlling cellular cholesterol transport and signal transduction. April 1, 2021.<\/p>\n Kecheng Zhou: Crosstalk between sphingolipid metabolism and nutrient signaling: Studies on LAPTM4B. March 4, 2021.<\/p>\n 2020<\/strong><\/p>\n Hanna Ruhanen: Hepatic lipid metabolism in cardiometabolic diseases \u2013 protective and adverse effects of genetic variants. October 13, 2020.<\/p>\n Dan Pham Duc: Novel roles of p75 neurotrophin receptor in Low-density lipoprotein receptor regulation and lipid signaling. June 4, 2020.<\/p>\n Veijo Salo: Lipogenic subdomains of the ER: The role of seipin. April 17, 2020.<\/p>\n Amr Abouelezz: The structure and dynamics of the actin cytoskeleton in the axon initial segment. February 28, 2020.<\/p>\n 2019<\/strong><\/p>\n Iryna Hlushchenko: Actin regulation in dendritic spines: From synaptic plasticity to animal behavior and neurodevelopmental disorders. August 16, 2019.<\/p>\n 2018<\/strong><\/p>\n Panu Luukkonen: Heterogeneity of non-alcoholic fatty liver disease \u2013 Genetic and nutritional modulation of hepatic lipid metabolism. September 7, 2018.<\/p>\n Henriikka Kentala: ORP2 \u2013 A sterol sensor controlling hepatocellular bioenergetics and actin cytoskeletal functions. August 18, 2018<\/p>\n Raghavendra Mysore: Novel molecular regulators of adipose tissue metabolism. May 18, 2018.<\/p>\n Anna Tikka: Characterization of ANGPTL3 deficiency and molecular mechanisms of ANGPTL3 deficiency-induced hypolipodemia. January 19, 2018.<\/p>\n Susanna Lallukka: Non-alcoholic fatty liver disease: The role of insulin resistance, inflammation and the PNPLA3 I148M variant. January 13, 2018.<\/p>\n 2017<\/strong><\/p>\n Jenni Hyysalo: Prevalence and Genetics of Non-Alcoholic Fatty Liver Disease. December 16, 2017.<\/p>\n Elina Isokuortti: Non-alcoholic fatty liver disease \u2013 Studies on pathogenesis and diagnosis. October 28, 2017.<\/p>\n Boris Vassilev: Studies on proteins influencing cancer progression and regulating endocytic lipid trafficking. April 28, 2017.<\/p>\n 2016<\/strong><\/p>\n Johanna M\u00e4kel\u00e4: Neuroprotective effects of PGC-1\u03b1 activators in dopaminergic neurons. May 20, 2016.<\/p>\n 2015<\/strong><\/p>\n Veronica Kalhori: Sphingosine-1-phosphate-evoked invasion of follicular thyroid cancer cells: Evidence for the involvement of HIF-1a, MMP2 and MMP9. September 11, 2015.<\/p>\n Tho Huu Ho: Development of amplification-based technologies for enrichment of nucleic acids with difficult sequences or low-abundance point mutations. February 13, 2015.<\/p>\n 2014<\/strong><\/p>\n Alise Hyrskyluoto: Endoplasmic reticulum stress, regulation of autophagy and ubiquitin-proteosome system in cellular models of Huntington’s Disease. September 12, 2014.<\/p>\n Leena Juurinen: Insulin therapy in type 2 diabetes – Initiation, impact on liver fat, role of combination therapy with glitazones or glinides. May 16, 2014.<\/p>\n Jere Paavola: Aberrant intracellular calcium cycling in the heart – Mechanistic insights into catecholaminergic polymorphic ventricular tachycardia and heart failure. March 28, 2014.<\/p>\n 2013<\/strong><\/p>\n Anders Eriksson-Paloj\u00e4rvi: Neurohumoral responce and pathophysiologic changes during progresson of mitral reurgitation in the Cavalier King Charles spaniel. November 29, 2013.<\/p>\n Wei Wang: Studies on the transcriptional and enzymatic control of steroid metabolism: Regulation by lysosomal acid lipase, 24-dehydrocholesterol reductace, and amyloid precursor protein. November 28, 2013.<\/p>\n Raili Koivuniemi: Regulation of neural progenitor cell proliferation and fate by proteolytic pathways and inflammatory signals in the brain. September 6, 2013.<\/p>\n You Zhou: Oxysterol binding protein homologues: Novel functions in intracellular transport and adipogenesis. January 25, 2013.<\/p>\n 2012<\/strong><\/p>\n Noora Putkonen: Organelle specific mechanism of neuronal cell death. October 26, 2012.<\/p>\n Terhi Vihervaara: The role of oxysterol binding proteins in macrophages. October 5, 2012.<\/p>\n Paulina Skrobuk: Glucose and lipid metabolism in human skeletal muscle. September 7, 2012.<\/p>\n 2011<\/strong><\/p>\n Ksenia Sevastianova: Combination antiretroviral therapy-associated lipodystrophy: insights into pathogenesis and treatment. November 25, 2011.<\/p>\n 2010<\/strong><\/p>\n P\u00e4ivi Lakkisto: Heme oxygenase-1 in cardiovascular diseases. December 17, 2010.<\/p>\n Minna Kairisalo: Oxidative stress and XIAP signalling in neuronal cells. October 15, 2010.<\/p>\n Sami Reijonen: Endoplasmic reticulum stress and cell death mechanisms in the cell model of Huntington’s disease. October 8, 2010.<\/p>\n Nina Bergelin: Interactions between sphingosine 1-phosphate and vascular endothelial growth factor signaling in thyroid carcinoma cells. September 17, 2010.<\/p>\n Tero Viitanen: GABAa reseptor mediated signalling in the brain: inhibition, shunting and excitation. June 23, 2010.<\/p>\n Janne Makkonen: Adipose tissue inflammation, liver fat and insulin resistance in humans. June 18, 2010.<\/p>\n 2008<\/strong><\/p>\n Anna Kotronen: Liver fat in the metabolic syndrome and type 2 diabetes.<\/p>\n 2007<\/strong><\/p>\n Cia Ramstr\u00f6m: Ceramides and DAG as regulators of potassium channel function.<\/p>\n 2006<\/strong><\/p>\n Tomas Blom: Sphingolipid-mediated regulation of cellular calcium signaling and survival.<\/p>\n 2005<\/strong><\/p>\n Mirja Tiikkainen: Effects of weight loss, rosiglitazone and metformin on liver fat content, insulin resistance and gene expression in adipose tissue\u201d<\/p>\n 2004<\/strong><\/p>\n Marjo Tamminen: Vascular and Platelet Function in Insulin Resistance<\/p>\n Esa Lepp\u00e4nen: Experimental basis for standardization of blood specimen collection. (started in Minerva but was completed in Jyv\u00e4skyl\u00e4)<\/p>\n 2003<\/strong><\/p>\n Elena Korsheninnikova: Molecular mechanisms of insulin resistance in human skeletal muscle and lipodystrophic adipose tissue. July 4, 2003.<\/p>\n Robert Bergholm: Effects of weight loss, physical training and anti-inflammatory therapy on endothelial function in vivo.<\/p>\n Jussi Sutinen: Pathogenesis and treatment of lipodystrophy in HIV-infected patients receiving highly active antiretroviral therapy.<\/p>\n 2002<\/strong><\/p>\n Nina Uhlenius: Angiotensin II and nitric oxide in chronic experimental nephritis.<\/p>\n 2001<\/strong><\/p>\n Jukka Westerbacka: Insulin action on large artery stiffness in normal and insulin resistant subjects.<\/p>\n Satu Vehkavaara: Identification and treatment of endothelial dysfunction and cardiovascular risk markers in disorders of glucose metabolism and in postmenopausal women.<\/p>\n 2000<\/strong><\/p>\n Beno\u00eet Dugu\u00e9: Variabilit\u00e9 Biologique. Influence des facteurs preanalytiques in vivo (stress physique, stress psychologique, chronobiologie) sur les r\u00e9sultants d\u2019analyses de marqueurs biologiques sanguins et cellulaires.<\/p>\n 1999<\/strong><\/p>\n Markus Sundblom: Neuropeptide FF in human blood and cerebrospinal fluid.<\/p>\n 1998<\/strong><\/p>\n Leena Karhap\u00e4\u00e4: Effects of caffeine and thimerosal on the regulation of intracellular calsium concentration in GH4C1 rat pituitary cells.<\/p>\n 1997<\/strong><\/p>\n Marja-Leena Sirvi\u00f6: Endothelin-1; cardiopulmonal expression, metabolism and regulation of atrial natriuretic peptide release.<\/p>\n 1995<\/strong><\/p>\n Antti Virkam\u00e4ki: Mechanism and causes of abnormal carbohydrate metabolism during experimental and natural infections.<\/p>\n 1994<\/strong><\/p>\n Outi Saijonmaa: Endothelin-1: Plasma levels in cold pressor test and regulation in endothelial cells.<\/p>\n Karri Helin: Neutral endopeptidase inhibition in experimental heart failure.<\/p>\n 1991<\/strong><\/p>\n Sari Tikanoja: Free thyroid hormones in serum: performance of different assay methodologies in thyroid diseases and non-thyroidal illnesses.<\/p>\n 1989<\/strong><\/p>\n Per-Henrik Groop: The relationship between gastric inhibitory polypeptide (GIP) and beta-cell function in man.<\/p>\n Tuula Tikkanen: Atrial natriuretic peptide in experimental heart failure.<\/p>\n Kaj Mets\u00e4rinne: Renin substrate in human plasma and amniotic fluid.<\/p>\n 1987<\/strong><\/p>\n Kid T\u00f6rnquist: 1,25-dihydroxyvitamin D3 and the secretion of thyrotropin and prolactin from the rat pituitary gland.<\/p>\n Katarina Rosenl\u00f6f: Erythropoietin: receptor and comparison with renin substrate.<\/p>\n 1986<\/strong><\/p>\n Virpi Oksanen: Neurosarcoidosis: A clinical, laboratory and neuroradiological study.<\/p>\n Jean-Louis Gu\u00e9ant:<\/p>\n 1984<\/strong><\/p>\n Markku M. Nieminen: Renin-Aldosterone axis in man following ingestion of ethanol.<\/p>\n Christel Lamberg-Allardt: Serum 25-hydroxy-vitamin D concentration and vitamin D intake.<\/p>\n Terje Forslund: Induction of rat angiotensin converting enzyme by captopril and enalapril.<\/p>\n 1983<\/strong><\/p>\n Ilkka Immonen: Factors affecting human plasma renin substrate concentration with emphasis on estrogens and pregnancy.<\/p>\n 1982<\/strong><\/p>\n Jaakko Linkola: Strain differences in water and electrolyte metabolism between alcohol preferring (AA) and alcohol avoiding (ANA) rats.<\/p>\n Tom Petterson: Pleural effusions in infectious, neoplastic and connective tissue diseases. A study of cellular and immunological reactions with emphasis on the role of T and B lymphoytes.<\/p>\n 1981<\/strong><\/p>\n Ilkka Kouvonen: Structure of the porcine intestinal intrinsic factor (IF) receptor.<\/p>\n Ilkka Tikkanen: Hypertensive effect of autoimmune nephritis in DOCA-NaCl-treated and in spontaneously hypertensive rats.<\/p>\n Georg Borgstr\u00f6m: Clinical implications of chromosome aberrations in hematologic neoplasia.<\/p>\n 1980<\/strong><\/p>\n Carola Gr\u00f6nhagen-Riska: Angiotensin converting enzyme and sarcoidosis.<\/p>\n Fredrika Pekonen: The interaction of thyrotropin with its receptors.<\/p>\n 1978<\/strong><\/p>\n Thomas T\u00f6tterman: Thyroid-infiltrating immunocompetent cells in human autoimmune thyroid disease.<\/p>\n George Marcoullis: Soluble and membrane-bound proteins involved in vitamin B12 transport.<\/p>\n Pertti Soveri: Renin in human pregnancy and during oral contraception.<\/p>\n 1975<\/strong><\/p>\n Gustav W\u00e4gar: Effect of TSH and cyclic adenosine 3\u00b4, 5\u00b4-monophosphate on thyroidal protein synthesis.<\/p>\n Jim Schr\u00f6der: Passage of blood cells between foetus and mother.<\/p>\n 1974<\/strong><\/p>\n Ariel Gordin: Thyrotrophin in human serum; A methodological and clinical study in diseases of the thyroid gland.<\/p>\n Ulf-H\u00e5kan Stenman: Studies on cobalophilin. Vitamin B12-binding proteins of R-type.<\/p>\n Ritva-Kajsa Selander: Kromosomala makromolekylers effekt p\u00e5 vissa akridinderivats absorption och fluorescens.<\/p>\n 1973<\/strong><\/p>\n Aldur Eriksson: Human twinning in and around the \u00c5land Islands.<\/p>\n 1972<\/strong><\/p>\n Jorma M\u00e4enp\u00e4\u00e4: Hypothyroidism and autoimmune thyroiditis in childhood.<\/p>\n Risto Kala: Venous plasma angiotensin II in man. Diurnal variation and response to various postural stimuli and exercise.<\/p>\n 1971<\/strong><\/p>\n Johan Wennstr\u00f6m: Effect of ionizing radiation on the chromosomes in meiotic and mitotic cells.<\/p>\n Frej Fyhrquist: Radioimmunoassay of plasma angiotensin II in patients with hypertension, in renal transplant recipients, and in anephric patients.<\/p>\n 1970<\/strong><\/p>\n Johan Edgren: Effect of cysteine on chromosome aberrations induced by radiation of human lymphocytes in vitro.<\/p>\n 1969<\/strong><\/p>\n Teddy Weber: Isolation and characterization of a lymphocyte-stimulating leucoagglutinin from red kidney beans. (Phaseolus vulgaris).<\/p>\n 1968<\/strong><\/p>\n Rolf Nordman: Endemic goitre in Finland in the light of thyroids of newborn in 1962-1965.<\/p>\n Kristian Liewendahl: Iodochloroxyquinoline and the thyroid gland. Metabolism of iodochloroxyquinoline iodine and its effect on the thyroid iodine metabolism in rats.<\/p>\n 1964<\/strong><\/p>\n Kaj Simons: Vitamin B12 binders in human body fluids and blood cells.<\/p>\n 1962<\/strong><\/p>\n Albert de la Chapelle: Cytogenetical and clinical observations in female gonadal dysgenesis.<\/p>\n<\/div><\/div><\/div><\/div><\/div><\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":0,"parent":758,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"100-width.php","meta":{"footnotes":""},"class_list":["post-773","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/minervainstitute.fi\/fi\/wp-json\/wp\/v2\/pages\/773","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/minervainstitute.fi\/fi\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/minervainstitute.fi\/fi\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/minervainstitute.fi\/fi\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/minervainstitute.fi\/fi\/wp-json\/wp\/v2\/comments?post=773"}],"version-history":[{"count":21,"href":"https:\/\/minervainstitute.fi\/fi\/wp-json\/wp\/v2\/pages\/773\/revisions"}],"predecessor-version":[{"id":2342,"href":"https:\/\/minervainstitute.fi\/fi\/wp-json\/wp\/v2\/pages\/773\/revisions\/2342"}],"up":[{"embeddable":true,"href":"https:\/\/minervainstitute.fi\/fi\/wp-json\/wp\/v2\/pages\/758"}],"wp:attachment":[{"href":"https:\/\/minervainstitute.fi\/fi\/wp-json\/wp\/v2\/media?parent=773"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}<\/span><\/div><\/div><\/div><\/div><\/div>